...
首页> 外文期刊>Pakistan journal of medical sciences. >Correlation between expression of epidermal growth factor receptor and adverse reactions after chemotherapy of advanced non-small-cell lung cancer
【24h】

Correlation between expression of epidermal growth factor receptor and adverse reactions after chemotherapy of advanced non-small-cell lung cancer

机译:晚期非小细胞肺癌化疗后表皮生长因子受体表达与不良反应的相关性

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Objective: To analyze the correlation between expression of epidermal growth factor receptor (EGFR) and adverse reactions after chemotherapy of advanced non-small-cell lung cancer (NSCLC).Methods: A total of 120 NSCLC patients who were treated in our hospital from August 2009 to September 2011 were selected as an observation group, and another 120 healthy subjects were selected as a control group. EGFR expressions in both groups were detected. The observation group was subjected to combination chemotherapy, and their shorter- and long-term prognostic outcomes, adverse reactions and mortality were recorded. Meanwhile, correlation analysis was performed.Results: The observation group had significantly higher percentage and positive rate in EGFR expression than those of the control group (P<0.05). With increasing stage and lymphatic metastasis, the positive expression rate of EGFR rose significantly (P<0.05). In the observation group, the response rate of treatment was 62.5%, and the incidence rate of adverse reactions after chemotherapy was 28.3% (34/120). The 1-, 2- and 3-year survival rates were 38.3%, 15.0% and 10.0% respectively. Multiple Logistic regression analysis showed that TNM stage, lymphatic metastasis and positive EGFR expression were the main independent risk factors for post-chemotherapy adverse reactions (P<0.05).Conclusion: Advanced NSCLC was commonly accompanied by high EGFR expression. Although chemotherapy was able to improve the prognosis and survival rate, adverse reactions were also induced, being associated with the pathological characteristics and EGFR expressions of patients.doi: http://dx.doi.org/10.12669/pjms.315.7939How to cite this:Hao Z, Tian C, Yang F, Zhang J. Correlation between expression of epidermal growth factor receptor and adverse reactions after chemotherapy of advanced non-small-cell lung cancer. Pak J Med Sci 2015;31(5):1115-1120. doi: http://dx.doi.org/10.12669/pjms.315.7939This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
机译:目的:分析表皮生长因子受体(EGFR)的表达与晚期非小细胞肺癌(NSCLC)化疗后不良反应的相关性。方法:我院自8月起共收治120例NSCLC患者。选择2009年至2011年9月作为观察组,另选择120名健康受试者作为对照组。检测两组中的EGFR表达。观察组接受了联合化疗,并记录了其短期和长期预后,不良反应和死亡率。结果:观察组EGFR表达的阳性率和阳性率明显高于对照组(P <0.05)。随着分期和淋巴结转移的增加,EGFR的阳性表达率明显升高(P <0.05)。观察组的治疗反应率为62.5%,化疗后不良反应的发生率为28.3%(34/120)。 1年,2年和3年生存率分别为38.3%,15.0%和10.0%。多元Logistic回归分析显示,TNM分期,淋巴转移和EGFR阳性表达是化疗后不良反应的主要独立危险因素(P <0.05)。结论:晚期NSCLC通常伴有EGFR高表达。尽管化学疗法能够改善预后和存活率,但也诱发了不良反应,与患者的病理特征和EGFR表达有关。doi:http://dx.doi.org/10.12669/pjms.315.7939如何引用郝Z,田C,杨F,张J.表皮生长因子受体表达与晚期非小细胞肺癌化疗后不良反应的相关性。 Pak J Med Sci 2015; 31(5):1115-1120。 doi:http://dx.doi.org/10.12669/pjms.315.7939。这是根据知识共享署名许可(http://creativecommons.org/licenses/by/3.0)的条款分发的开放获取文章,只要适当引用了原始作品,便可以在任何介质中不受限制地使用,分发和复制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号